Endovascular Parent Vessel Occlusion versus Flow diversion in the Treatment of Large and Giant Aneurysms: A randomized comparison

William Boisseau,Tim E Darsaut,Robert Fahed,Pierre Olivier Comby,Brian Drake,Howard Lesiuk,Jeremy L Rempel,Cian J O'Kelly,Michael M C Chow,Daniela Iancu,Daniel Roy,Alain Weill,Ruby Klink,Jean Raymond,Tim E. Darsaut,Jeremy L. Rempel,Cian J. O’Kelly,Michael M.C. Chow
DOI: https://doi.org/10.1016/j.wneu.2024.02.114
IF: 2.21
2024-02-01
World Neurosurgery
Abstract:BACKGROUND AND PURPOSE: Parent vessel occlusion (PVO) is a time-honored treatment for unclippable or uncoilable intracranial aneurysms. Flow diversion (FD) is a recent endovascular alternative that can occlude the aneurysm and spare the parent blood vessel. Our aim was to compare outcomes of FD with endovascular PVO.MATERIALS AND METHODS: This is a pre-specified treatment subgroup analysis of the Flow diversion in Intracranial Aneurysms trial (FIAT). FIAT was an investigator-led parallel-group all-inclusive pragmatic randomized trial. For each patient, clinicians had to pre-specify an alternative management option to FD before stratified randomization. We report all patients for whom PVO was selected as the best alternative treatment to FD. The primary outcome was a composite of core-lab determined angiographic occlusion or near-occlusion at 3-12 months combined with an independent clinical outcome (mRS<3). Primary analyses were intent-to-treat. There was no blinding.RESULTS: There were 45 patients (16.2% of the 278 FIAT patients randomized between 2011 and 2020 in 3 centers): 22 were randomly allocated to FD and 23 to PVO. Aneurysms were mainly large or giant (mean 22mm) anterior circulation (mainly carotid) aneurysms. A poor primary outcome was reached in 11/22 FD (50.0%) compared to 9/23 PVO patients (39.1%) (RR: 1.28, 95%CI [0.66-2.47]; P=.466). Morbidity (mRS >2) at 1 year occurred in 4/22 FD and 6/23 PVO patients. Angiographic results and serious adverse events were similar.CONCLUSIONS: The comparison between PVO and FD was inconclusive. More randomized trials are needed to better determine the role of FD in large aneurysms eligible for PVO.
surgery,clinical neurology
What problem does this paper attempt to address?